| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |